Respiratory Tract Diseases  >>  Alvesco (ciclesonide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
NCT00174746: Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

Completed
2
1145
US
AVE2635A
Sanofi
Asthma
11/05
11/05
NCT00314509 / 2004-004708-19: Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Completed
2
240
Europe, RoW
Ciclesonide/Formoterol Combination
AstraZeneca
Asthma
01/06
01/06
NCT00535366 / 2007-003169-42: Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD

Completed
2
103
Europe
Tiotropium, Salmeterol, Fluticasone, Ciclesonide low, Ciclesonide high, Placebo
Boehringer Ingelheim
Pulmonary Disease, Chronic Obstructive
09/08
 

Download Options